Research ArticleOncology
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li and Mingzhao Xing
Journal of Nuclear Medicine February 2020, 61 (2) 177-182; DOI: https://doi.org/10.2967/jnumed.119.227652
Jiajun Liu
1Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
2Department of Nuclear Medicine, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Rengyun Liu
1Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
Xiaopei Shen
1Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
Guangwu Zhu
1Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
Biao Li
2Department of Nuclear Medicine, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Mingzhao Xing
1Laboratory for Cellular and Molecular Thyroid Research, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 2
February 1, 2020
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li, Mingzhao Xing
Journal of Nuclear Medicine Feb 2020, 61 (2) 177-182; DOI: 10.2967/jnumed.119.227652
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
Jiajun Liu, Rengyun Liu, Xiaopei Shen, Guangwu Zhu, Biao Li, Mingzhao Xing
Journal of Nuclear Medicine Feb 2020, 61 (2) 177-182; DOI: 10.2967/jnumed.119.227652